調剤薬局の世界市場 2023-2027

調剤薬局市場は2022-2027年に16億8,204万米ドル、予測期間中のCAGRは2.18%で成長すると予測されています。

この調査レポートは、調剤薬局市場の全体分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、配合薬の需要を煽るHRTの人気の高まり、ホルモンバランスの問題の有病率の増加、政府の規制やイニシアチブによって牽引されています。

本調査では、今後数年間の調剤薬局市場の成長を促進する主な要因の1つとして、個別化医薬品の人気の高まりを挙げています。また、新興市場における未開拓のビジネスチャンスや世界の必須医薬品の不足は、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 調剤薬局の世界市場 2017-2021
• 製品セグメント分析 2017-2021
• 治療領域セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• 外用薬：市場規模と予測 2022-2027
• 経口薬：市場規模と予測 2022-2027
• 非経口薬：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：製品別

第7章 市場セグメンテーション治療領域別

• 市場セグメント
• 比較治療領域別
• 疼痛管理：市場規模と予測 2022-2027
• ホルモン補充：市場規模と予測 2022-2027
• 皮膚疾患：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会治療領域別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• フランス：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Advance Pharmacy
• Athenex Inc.
• B.Braun SE
• Fagron NV
• Fresenius SE and Co. KGaA
• Institutional Pharmacy Solutions
• ITC Compounding Pharmacy
• McGuff Co. Inc.
• Nephron Pharmaceuticals Corp.
• Olympia Pharmacy
• PenCol Specialty Pharmacy
• Rx3 Compounding Pharmacy
• Triangle Compounding Pharmacy
• Valor Compounding Pharmacy
• Wedgewood Village Pharmacy LLC

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global compounding pharmacy market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Therapeutic Area Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Topical medications - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Topical medications - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Topical medications - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Topical medications - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Oral medications - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Oral medications - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Oral medications - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Oral medications - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Parenteral medications - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Parenteral medications - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Parenteral medications - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Parenteral medications - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Product ($ million)
• Exhibits51: Data Table on Market opportunity by Product ($ million)
• Exhibits52: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits53: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits54: Chart on Comparison by Therapeutic Area
• Exhibits55: Data Table on Comparison by Therapeutic Area
• Exhibits56: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Pain management - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Hormone replacement - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Hormone replacement - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Hormone replacement - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Hormone replacement - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Dermal disorders - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Data Table on Dermal disorders - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Chart on Dermal disorders - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Dermal disorders - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits72: Market opportunity by Therapeutic Area ($ million)
• Exhibits73: Data Table on Market opportunity by Therapeutic Area ($ million)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits113: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ million)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits117: Impact of drivers and challenges in 2022 and 2027
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: Advance Pharmacy - Overview
• Exhibits124: Advance Pharmacy - Product / Service
• Exhibits125: Advance Pharmacy - Key offerings
• Exhibits126: Athenex Inc. - Overview
• Exhibits127: Athenex Inc. - Product / Service
• Exhibits128: Athenex Inc. - Key offerings
• Exhibits129: B.Braun SE - Overview
• Exhibits130: B.Braun SE - Business segments
• Exhibits131: B.Braun SE - Key news
• Exhibits132: B.Braun SE - Key offerings
• Exhibits133: B.Braun SE - Segment focus
• Exhibits134: Fagron NV - Overview
• Exhibits135: Fagron NV - Business segments
• Exhibits136: Fagron NV - Key news
• Exhibits137: Fagron NV - Key offerings
• Exhibits138: Fagron NV - Segment focus
• Exhibits139: Fresenius SE and Co. KGaA - Overview
• Exhibits140: Fresenius SE and Co. KGaA - Business segments
• Exhibits141: Fresenius SE and Co. KGaA - Key news
• Exhibits142: Fresenius SE and Co. KGaA - Key offerings
• Exhibits143: Fresenius SE and Co. KGaA - Segment focus
• Exhibits144: Institutional Pharmacy Solutions - Overview
• Exhibits145: Institutional Pharmacy Solutions - Product / Service
• Exhibits146: Institutional Pharmacy Solutions - Key offerings
• Exhibits147: ITC Compounding Pharmacy - Overview
• Exhibits148: ITC Compounding Pharmacy - Product / Service
• Exhibits149: ITC Compounding Pharmacy - Key offerings
• Exhibits150: McGuff Co. Inc. - Overview
• Exhibits151: McGuff Co. Inc. - Product / Service
• Exhibits152: McGuff Co. Inc. - Key offerings
• Exhibits153: Nephron Pharmaceuticals Corp. - Overview
• Exhibits154: Nephron Pharmaceuticals Corp. - Product / Service
• Exhibits155: Nephron Pharmaceuticals Corp. - Key offerings
• Exhibits156: Olympia Pharmacy - Overview
• Exhibits157: Olympia Pharmacy - Product / Service
• Exhibits158: Olympia Pharmacy - Key offerings
• Exhibits159: PenCol Specialty Pharmacy - Overview
• Exhibits160: PenCol Specialty Pharmacy - Product / Service
• Exhibits161: PenCol Specialty Pharmacy - Key offerings
• Exhibits162: Rx3 Compounding Pharmacy - Overview
• Exhibits163: Rx3 Compounding Pharmacy - Product / Service
• Exhibits164: Rx3 Compounding Pharmacy - Key offerings
• Exhibits165: Triangle Compounding Pharmacy - Overview
• Exhibits166: Triangle Compounding Pharmacy - Product / Service
• Exhibits167: Triangle Compounding Pharmacy - Key offerings
• Exhibits168: Valor Compounding Pharmacy - Overview
• Exhibits169: Valor Compounding Pharmacy - Product / Service
• Exhibits170: Valor Compounding Pharmacy - Key offerings
• Exhibits171: Wedgewood Village Pharmacy LLC - Overview
• Exhibits172: Wedgewood Village Pharmacy LLC - Product / Service
• Exhibits173: Wedgewood Village Pharmacy LLC - Key offerings
• Exhibits174: Inclusions checklist
• Exhibits175: Exclusions checklist
• Exhibits176: Currency conversion rates for US$
• Exhibits177: Research methodology
• Exhibits178: Validation techniques employed for market sizing
• Exhibits179: Information sources
• Exhibits180: List of abbreviations

The compounding pharmacy market is forecasted to grow by USD 1,682.04 million mn during 2022-2027, accelerating at a CAGR of 2.18% during the forecast period. The report on the compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing popularity of HRT fueling demand for compounded medications, the increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.

Technavio's compounding pharmacy market is segmented as below:

By Product

• Topical medications
• Oral medications
• Parenteral medications
• Other medications

By Therapeutic Area

• Pain management
• Hormone replacement
• Dermal disorders
• Other therapeutic areas

By Geographical Landscape

• North America
• The U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Rest of Europe
• Asia
• China
• India
• ROW
• Australia
• Argentina
• Rest of the world

This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and a global shortage of essential drugs will lead to sizable demand in the market.

The report on the compounding pharmacy market covers the following areas:

• Compounding pharmacy market sizing
• Compounding pharmacy market forecast
• Compounding pharmacy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading compounding pharmacy market vendors that include ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. Also, the compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global compounding pharmacy market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global compounding pharmacy market 2017 - 2021 ($ million)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.3 Therapeutic Area Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Therapeutic Area Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Topical medications - Market size and forecast 2022-2027
• Exhibit 34: Chart on Topical medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Topical medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Topical medications - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Topical medications - Year-over-year growth 2022-2027 (%)
• 6.4 Oral medications - Market size and forecast 2022-2027
• Exhibit 38: Chart on Oral medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Oral medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Oral medications - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Oral medications - Year-over-year growth 2022-2027 (%)
• 6.5 Parenteral medications - Market size and forecast 2022-2027
• Exhibit 42: Chart on Parenteral medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Parenteral medications - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Parenteral medications - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Parenteral medications - Year-over-year growth 2022-2027 (%)
• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Product
• Exhibit 50: Market opportunity by Product ($ million)
• Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Therapeutic Area

• 7.1 Market segments
• Exhibit 52: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibit 53: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• 7.2 Comparison by Therapeutic Area
• Exhibit 54: Chart on Comparison by Therapeutic Area
• Exhibit 55: Data Table on Comparison by Therapeutic Area
• 7.3 Pain management - Market size and forecast 2022-2027
• Exhibit 56: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Pain management - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
• 7.4 Hormone replacement - Market size and forecast 2022-2027
• Exhibit 60: Chart on Hormone replacement - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Hormone replacement - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Hormone replacement - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Hormone replacement - Year-over-year growth 2022-2027 (%)
• 7.5 Dermal disorders - Market size and forecast 2022-2027
• Exhibit 64: Chart on Dermal disorders - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Dermal disorders - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Dermal disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Dermal disorders - Year-over-year growth 2022-2027 (%)
• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Therapeutic Area
• Exhibit 72: Market opportunity by Therapeutic Area ($ million)
• Exhibit 73: Data Table on Market opportunity by Therapeutic Area ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 France - Market size and forecast 2022-2027
• Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 115: Market opportunity By Geographical Landscape ($ million)
• Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Advance Pharmacy
• Exhibit 123: Advance Pharmacy - Overview
• Exhibit 124: Advance Pharmacy - Product / Service
• Exhibit 125: Advance Pharmacy - Key offerings
• 12.4 Athenex Inc.
• Exhibit 126: Athenex Inc. - Overview
• Exhibit 127: Athenex Inc. - Product / Service
• Exhibit 128: Athenex Inc. - Key offerings
• 12.5 B.Braun SE
• Exhibit 129: B.Braun SE - Overview
• Exhibit 130: B.Braun SE - Business segments
• Exhibit 131: B.Braun SE - Key news
• Exhibit 132: B.Braun SE - Key offerings
• Exhibit 133: B.Braun SE - Segment focus
• 12.6 Fagron NV
• Exhibit 134: Fagron NV - Overview
• Exhibit 135: Fagron NV - Business segments
• Exhibit 136: Fagron NV - Key news
• Exhibit 137: Fagron NV - Key offerings
• Exhibit 138: Fagron NV - Segment focus
• 12.7 Fresenius SE and Co. KGaA
• Exhibit 139: Fresenius SE and Co. KGaA - Overview
• Exhibit 140: Fresenius SE and Co. KGaA - Business segments
• Exhibit 141: Fresenius SE and Co. KGaA - Key news
• Exhibit 142: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 143: Fresenius SE and Co. KGaA - Segment focus
• 12.8 Institutional Pharmacy Solutions
• Exhibit 144: Institutional Pharmacy Solutions - Overview
• Exhibit 145: Institutional Pharmacy Solutions - Product / Service
• Exhibit 146: Institutional Pharmacy Solutions - Key offerings
• 12.9 ITC Compounding Pharmacy
• Exhibit 147: ITC Compounding Pharmacy - Overview
• Exhibit 148: ITC Compounding Pharmacy - Product / Service
• Exhibit 149: ITC Compounding Pharmacy - Key offerings
• 12.10 McGuff Co. Inc.
• Exhibit 150: McGuff Co. Inc. - Overview
• Exhibit 151: McGuff Co. Inc. - Product / Service
• Exhibit 152: McGuff Co. Inc. - Key offerings
• 12.11 Nephron Pharmaceuticals Corp.
• Exhibit 153: Nephron Pharmaceuticals Corp. - Overview
• Exhibit 154: Nephron Pharmaceuticals Corp. - Product / Service
• Exhibit 155: Nephron Pharmaceuticals Corp. - Key offerings
• 12.12 Olympia Pharmacy
• Exhibit 156: Olympia Pharmacy - Overview
• Exhibit 157: Olympia Pharmacy - Product / Service
• Exhibit 158: Olympia Pharmacy - Key offerings
• 12.13 PenCol Specialty Pharmacy
• Exhibit 159: PenCol Specialty Pharmacy - Overview
• Exhibit 160: PenCol Specialty Pharmacy - Product / Service
• Exhibit 161: PenCol Specialty Pharmacy - Key offerings
• 12.14 Rx3 Compounding Pharmacy
• Exhibit 162: Rx3 Compounding Pharmacy - Overview
• Exhibit 163: Rx3 Compounding Pharmacy - Product / Service
• Exhibit 164: Rx3 Compounding Pharmacy - Key offerings
• 12.15 Triangle Compounding Pharmacy
• Exhibit 165: Triangle Compounding Pharmacy - Overview
• Exhibit 166: Triangle Compounding Pharmacy - Product / Service
• Exhibit 167: Triangle Compounding Pharmacy - Key offerings
• 12.16 Valor Compounding Pharmacy
• Exhibit 168: Valor Compounding Pharmacy - Overview
• Exhibit 169: Valor Compounding Pharmacy - Product / Service
• Exhibit 170: Valor Compounding Pharmacy - Key offerings
• 12.17 Wedgewood Village Pharmacy LLC
• Exhibit 171: Wedgewood Village Pharmacy LLC - Overview
• Exhibit 172: Wedgewood Village Pharmacy LLC - Product / Service
• Exhibit 173: Wedgewood Village Pharmacy LLC - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 176: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources
• 13.5 List of abbreviations
• Exhibit 180: List of abbreviations